Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Queen RX vs Tru2u

Queen RX
Graded #214

Higher grade

vs+1.5999999999999943
Tru2u
Graded #244

Lower grade

The verdict

Queen RX takes it — 66/100 to 64.4/100, but only just.

Queen RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo). Tru2u is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +20
76
56
Dose & formulationTru2u +26
57
83
Clinical oversightQueen RX +1
69
68
Labs & monitoringQueen RX +2
53
51
FulfillmentQueen RX +7
75
68
Contract termsQueen RX +6
61
55
Queen RX · left barTru2u · right bar

The numbers

MetricQueen RXTru2u
WeighScore66/10064.4/100
GradeCC
Scorecard rank#214#244
Semaglutide$100/mo (quarterly plan, compounded)$225/mo
TirzepatideNot disclosed$345/mo
Coverage45 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Queen RX

Graded #214 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV
Tru2u

Graded #244 · C

Strengths

  • Offers compounded semaglutide and tirzepatide plus a combined GLP Squared injection
  • Both injectable and oral GLP-1 tablet options available
  • Transparent upfront monthly pricing with free shipping

Where it loses points

  • No compounding pharmacy publicly named and no LegitScript seal shown
  • Tirzepatide at 345 dollars per month is higher than many compounded competitors
  • States served are not published; site states US-only availability

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard